These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36999480)

  • 41. Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin.
    Teivelis MP; Wolosker N; Krutman M; Milanez de Campos JR; Kauffman P; Puech-Leão P
    Ann Thorac Surg; 2014 Nov; 98(5):1797-802. PubMed ID: 25173719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival study of treatment adherence by patients given oral oxibutynin for hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; García-Montero P; García-Harana C; Rivas Ruiz F; de Troya-Martín M
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1034-1037. PubMed ID: 29220103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fractionated microneedle radiofrequency for treatment of primary axillary hyperhidrosis: A sham control study.
    Fatemi Naeini F; Abtahi-Naeini B; Pourazizi M; Nilforoushzadeh MA; Mirmohammadkhani M
    Australas J Dermatol; 2015 Nov; 56(4):279-84. PubMed ID: 25496000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized trial - oxybutynin for treatment of persistent plantar hyperhidrosis in women after sympathectomy.
    Costa Ada S; Leão LE; Succi JE; Perfeito JA; Filho Castelo A; Rymkiewicz E; Filho Aurelio Marchetti M
    Clinics (Sao Paulo); 2014 Feb; 69(2):101-5. PubMed ID: 24519200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daily pattern of sweating and response to stress and exercise in patients with palmar hyperhidrosis.
    Krogstad AL; Mork C; Piechnik SK
    Br J Dermatol; 2006 Jun; 154(6):1118-22. PubMed ID: 16704643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis.
    El Kahky HM; Diab HM; Aly DG; Farag NM
    Dermatol Res Pract; 2013; 2013():686329. PubMed ID: 24250334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thoracoscopic sympathotomy for palmar hyperhidrosis: How young is too young?
    Vasconcelos-Castro S; Soares-Oliveira M; Tuna T; Borges-Dias M
    J Pediatr Surg; 2020 Nov; 55(11):2362-2365. PubMed ID: 31870560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initial study of transdermal oxybutynin for treating hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; Toledo-Pastrana T; Nieto-Guindo M; García-Montero P; de Troya-Martín M
    J Dermatol; 2017 Jun; 44(6):717-720. PubMed ID: 28106275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous Radiofrequency Sympatholysis in the Treatment of Primary Palmar Hyperhidrosis: A Retrospective Case-Controlled Study of Rib-Based Anatomical Targeting.
    Wu Y; Zhou Z; Zhang W; Tian S; Li C; He F; Chen G
    J Vasc Interv Radiol; 2023 Jan; 34(1):108-115. PubMed ID: 36182001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of oxybutynin for treatment of hyperhidrosis in overweight and obese patients.
    Wolosker N; Krutman M; Kauffman P; Paula RP; Campos JR; Puech-Leão P
    Rev Assoc Med Bras (1992); 2013; 59(2):143-7. PubMed ID: 23582555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
    Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok RD; Quiring J; Drew J; Pariser DM
    Am J Clin Dermatol; 2019 Aug; 20(4):593-604. PubMed ID: 31111409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Pilot Study of the Safety and Effectiveness of a Novel Device in Subjects With Axillary Hyperhidrosis.
    Kaufman J; Green JB; Cazzaniga A; Canty DJ; Tims E; Waugh J
    Dermatol Surg; 2022 Nov; 48(11):1220-1225. PubMed ID: 36129240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Translation and validation of Hyperhidrosis Disease Severity Scale.
    Varella AY; Fukuda JM; Teivelis MP; Campos JR; Kauffman P; Cucato GG; Puech-Leão P; Wolosker N
    Rev Assoc Med Bras (1992); 2016 Dec; 62(9):843-847. PubMed ID: 28001258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the Efficacy of Tap Water Iontophoresis Versus Aluminum Chloride Hexahydrate in the Treatment of Palmoplantar Hyperhidrosis.
    Rahim M; Ahmed N; Naz Khan K; Memon S; Naveed T; Shah SA; Farooq O; Ali U
    Cureus; 2022 Dec; 14(12):e32367. PubMed ID: 36627989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical evaluation of a microwave device for treating axillary hyperhidrosis.
    Hong HC; Lupin M; O'Shaughnessy KF
    Dermatol Surg; 2012 May; 38(5):728-35. PubMed ID: 22452511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial.
    Campanati A; Giuliodori K; Martina E; Giuliano A; Ganzetti G; Offidani A
    J Neural Transm (Vienna); 2014 Jan; 121(1):21-6. PubMed ID: 24052109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Study on the Impact of Hyperhidrosis on the Quality of Life among College Students.
    Muthusamy A; Gajendran R; Ponnan S; Thangavel D; Rangan V
    J Clin Diagn Res; 2016 Jun; 10(6):CC08-10. PubMed ID: 27504282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of compensatory sweating and quality of life following thoracic sympathetic block for palmar hyperhidrosis: electrocautery hook versus titanium clip.
    Wang FG; Chen YB; Yang WT; Shi L
    Chin Med J (Engl); 2011 Nov; 124(21):3495-8. PubMed ID: 22340165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plantar hyperhidrosis associated with primary palmar hyperhidrosis: Outcome following video-assisted thoracoscopic sympathectomy.
    Abu Arab WS; Elhamami MM
    Asian Cardiovasc Thorac Ann; 2021 May; 29(4):310-317. PubMed ID: 33611949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
    J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.